Punjab jails are seeing a major surge in the supply of Buprenorphine, a drug used to treat substance addiction. According to a report, 8.87 crore tablets have been supplied to jails this year alone, a sharp rise from 1.17 crore tablets in 2022. The figures highlight the scale of drug addiction among inmates across Punjab prisons.
Buprenorphine Supply in Punjab Jails Shows Sharp Increase
The Punjab Health Systems Corporation has been responsible for supplying these tablets to jails. The data shows a significant jump in the numbers over the past few years. As many as 40,830 inmates have been registered for treatment in jails between 2022 and the present, according to The Tribune.
The overall scale of the program is even larger. The Punjab government has purchased 43.44 crore tablets of Buprenorphine over the past four-and-a-half years. These tablets have been supplied to lakhs of people seeking treatment for drug abuse across the state, as reported by The New Indian Express.
Inmate Treatment Numbers Reveal Extent of Drug Addiction
The rise in tablet supply to jails points to a growing need for addiction treatment among prisoners. The figures were shared by Aam Aadmi Party MLA from Bathinda, Jagrup Singh Gill. He noted that while around 1.17 crore tablets were supplied to jails in 2022, the figure had increased to nearly 8.87 crore this year, according to The Indian Express.
"This year alone, 8.87 crore tablets have so far been supplied in jails by the Punjab Health Systems Corporation, a sharp rise from 1.17 crore tablets supplied in 2022." — The Tribune on Instagram
The data reveals a troubling trend. The number of tablets supplied to jails has grown nearly eight times in just a few years. This suggests that drug addiction remains a serious problem among the inmate population in Punjab.
- 8.87 crore Buprenorphine tablets supplied to Punjab jails this year
- 1.17 crore tablets supplied in 2022, showing a sharp year-on-year rise
- 40,830 inmates registered for treatment in jails since 2022
- 43.44 crore tablets purchased by the state government in four-and-a-half years
Our Take: A Sign of Both Progress and Concern
To put it plainly, these numbers tell two stories at once. On one hand, the sharp rise in Buprenorphine supply to jails shows that the system is actively treating inmates with addiction issues. That is a positive step — prisoners are getting medical help rather than being ignored.
On the other hand, the scale of the increase is worrying. An eight-fold jump in tablet supply within a few years means drug addiction inside Punjab's jails is widespread and possibly growing. The fact that over 40,000 inmates have needed treatment is a clear signal that the state faces a deep-rooted problem.
In our view, this report should push authorities to look beyond just supplying tablets. While treatment is essential, the state must also examine why so many inmates are addicted in the first place. Rehabilitation programs, counselling, and post-release support are just as important as the medicine itself. The surge in numbers is a reminder that the fight against drug abuse in Punjab is far from over.
Sources & References
- The Tribune — Punjab jails see surge in Buprenorphine supply
- The New Indian Express — Punjab supplied 43.44 crore buprenorphine tablets
- The Indian Express — Punjab procured 43 crore buprenorphine tablets
- The Tribune on Instagram — Buprenorphine supply figures
- The Tribune on X — Report on Buprenorphine supply